REVISIT OUR TARGETS

In the current Covid situation we should revisit
our targets which may be following

  • To reduce panic, confusion, misinformation amongst common man
  • To give a clear guideline about who should require Hospitalization for Covid
  • To let people at large understand that Remedesivir is “No Sanjivani”

I have some suggestions for consideration
of all of you

  • SPO2 Monitoring is the single most important parameter which can be used
    to decide who should be hospitalized
  • WITH More than 96% SPO2 Patients require only isolation and don’t require
    any investigations including HRCT
  • Patients with less than 94 should be recommended Hospitalization
  • Patients with SPO2 94 TO 96 SHOULD be closely monitored in his house
  • Associated comorbidities may have a bearing on decision making
  • Remedesivir is a drug on trial as yet and its efficacy is subject of debate
  • Steroids not to be used if no hypoxia on room air
  • Remdesivir is only useful in select group of patients
  • Convalescent plasma has absolutely no role in critical patients

Call & Whatsapp: +91 9352545803

DR. NARENDRA RUNGTA
MD FCCM FICCM FISCCM

For any queries, please contact

Email: info.criticalcarefoundation@gmail.com

  

Leave a Reply

Your email address will not be published.

You may use these <abbr title="HyperText Markup Language">HTML</abbr> tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

*